Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RESnTEC Institute of Research is a specialized biotechnology and medical research organization based in Tel Aviv, Israel, founded and led by Professor Shimon Slavin. The institute focuses on the development and clinical application of innovative protocols in cancer immunotherapy, regenerative medicine, and the treatment of autoimmune diseases. Its core expertise includes non-myeloablative stem cell transplantation, the use of mesenchymal stem cells for tissue repair, and the application of activated natural killer (NK) cells and personalized cancer vaccines. RESnTEC serves as the primary research and development vehicle for Biotherapy International, translating experimental cellular therapies into clinical practice for patients with life-threatening conditions that have failed standard treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RESnTEC Institute of Research.